Stocks and Investing Stocks and Investing
Tue, July 12, 2022
Mon, July 11, 2022
Sun, July 10, 2022
Fri, July 8, 2022

Vikram Purohit Maintained (AXSM) at Hold with Increased Target to $54 on, Jul 8th, 2022


Published on 2024-10-27 21:49:08 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Increased Target from $27 to $54 on, Jul 8th, 2022.

Vikram has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Vikram


  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
  • Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $49 on, Tuesday, May 3rd, 2022
  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Increased Target to $77 on, Tuesday, March 29th, 2022